Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mee Y Bartee

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|February 3, 2007
Hepatic copper-transporting ATPase ATP7B: function and inactivation at the molecular and cellular levelMee Y Bartee, Svetlana Lutsenko
Oncolytic Virotherapy|December 19, 2019
Impact of Induced Syncytia Formation on the Oncolytic Potential of Myxoma VirusChase Burton, Mee Y Bartee, Eric Bartee
Biochemistry|May 2, 2009
The loop connecting metal-binding domains 3 and 4 of ATP7B is a target of a kinase-mediated phosphorylationMee Y Bartee, Martina Ralle, Svetlana Lutsenko
Journal for Immunotherapy of Cancer|January 18, 2019
Chimeric tumor modeling reveals role of partial PDL1 expression in resistance to virally induced immunotherapyMee Y Bartee, Parker C Dryja, Eric Bartee
Cancer Research|March 19, 2017
Tumor-Localized Secretion of Soluble PD1 Enhances Oncolytic VirotherapyMee Y Bartee, Katherine M Dunlap, Eric Bartee
Clinical Lymphoma, Myeloma & Leukemia|January 25, 2016
Myxoma Virus Induces Ligand Independent Extrinsic Apoptosis in Human Myeloma CellsMee Y Bartee, Katherine M Dunlap, Eric Bartee
Oncolytic Virotherapy|August 12, 2016
Myxoma virus attenuates expression of activating transcription factor 4 (ATF4) which has implications for the treatment of proteasome inhibitor-resistant multiple myelomaKatherine M Dunlap, Mee Y Bartee, Eric Bartee
Plos One|May 1, 2020
Reduced cellular binding affinity has profoundly different impacts on the spread of distinct poxvirusesErica B Flores, Mee Y Bartee, Eric Bartee
Journal for Immunotherapy of Cancer|June 3, 2023
Defects in intratumoral arginine metabolism attenuate the replication and therapeutic efficacy of oncolytic myxoma virusParker Dryja, Heather D Curtsinger, Mee Y Bartee, et al.
Molecular Therapy Oncolytics|December 10, 2016
Systemic therapy with oncolytic myxoma virus cures established residual multiple myeloma in miceEric Bartee, Mee Y Bartee, Bjarne Bogen, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|February 3, 2007
Hepatic copper-transporting ATPase ATP7B: function and inactivation at the molecular and cellular levelMee Y Bartee, Svetlana Lutsenko
Oncolytic Virotherapy|December 19, 2019
Impact of Induced Syncytia Formation on the Oncolytic Potential of Myxoma VirusChase Burton, Mee Y Bartee, Eric Bartee
Biochemistry|May 2, 2009
The loop connecting metal-binding domains 3 and 4 of ATP7B is a target of a kinase-mediated phosphorylationMee Y Bartee, Martina Ralle, Svetlana Lutsenko
Journal for Immunotherapy of Cancer|January 18, 2019
Chimeric tumor modeling reveals role of partial PDL1 expression in resistance to virally induced immunotherapyMee Y Bartee, Parker C Dryja, Eric Bartee
Cancer Research|March 19, 2017
Tumor-Localized Secretion of Soluble PD1 Enhances Oncolytic VirotherapyMee Y Bartee, Katherine M Dunlap, Eric Bartee
Clinical Lymphoma, Myeloma & Leukemia|January 25, 2016
Myxoma Virus Induces Ligand Independent Extrinsic Apoptosis in Human Myeloma CellsMee Y Bartee, Katherine M Dunlap, Eric Bartee
Oncolytic Virotherapy|August 12, 2016
Myxoma virus attenuates expression of activating transcription factor 4 (ATF4) which has implications for the treatment of proteasome inhibitor-resistant multiple myelomaKatherine M Dunlap, Mee Y Bartee, Eric Bartee
Plos One|May 1, 2020
Reduced cellular binding affinity has profoundly different impacts on the spread of distinct poxvirusesErica B Flores, Mee Y Bartee, Eric Bartee
Journal for Immunotherapy of Cancer|June 3, 2023
Defects in intratumoral arginine metabolism attenuate the replication and therapeutic efficacy of oncolytic myxoma virusParker Dryja, Heather D Curtsinger, Mee Y Bartee, et al.
Molecular Therapy Oncolytics|December 10, 2016
Systemic therapy with oncolytic myxoma virus cures established residual multiple myeloma in miceEric Bartee, Mee Y Bartee, Bjarne Bogen, et al.
Pageof 3